6-iodo-7-methoxy-1,4-dihydroquinazolin-4-one, 98%, 250mg

1-(4-(Bromomethyl)phenyl)-1H-pyrazole, 95.0%, 1g

Methyl N-(diphenylmethylene)glycinate, 95.0%, 100g

Nicotinic Acid [Matrix for MALDI-TOF/MS]>99.5%(HPLC)(T)5g

tert-Butyl 7-azabicyclo[2.2.1]heptan-2-ylcarbamate hydrochloride, 97.0%, 1g

N1,N1,N4,N4-Tetra(pyridin-4-yl)benzene-1,4-diamine, 98%, 5g

GC capillary column ROTI®Cap-XLB, 30 m, 1 Piece(s)

(R)-2-((tert-Butoxycarbonyl)amino)-3-hydroxy-2-methylpropanoic acid, 95.0%, 250mg

2,8-Dichloro-7-methylquinoline, 97%, 100mg

Selenium(IV) oxide, ROTI®METIC 99.999% (5N), 10 g, glass packaging

Thalidomide-O-amido-PEG2-C2-NH2 (TFA), 1g

3-Cyano-2,6-dihydroxy-4-(trifluoromethyl)pyridine, 95.0%, 1g

5-Chloro-2-(diethylamino)pyrimidine-4-carboxylic acid, 95%, 250mg